Chris Reading

705 total citations
31 papers, 589 citations indexed

About

Chris Reading is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Chris Reading has authored 31 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 8 papers in Genetics. Recurrent topics in Chris Reading's work include Hematopoietic Stem Cell Transplantation (7 papers), Estrogen and related hormone effects (6 papers) and Hormonal and reproductive studies (5 papers). Chris Reading is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Estrogen and related hormone effects (6 papers) and Hormonal and reproductive studies (5 papers). Chris Reading collaborates with scholars based in United States, Netherlands and Mexico. Chris Reading's co-authors include Rajeev Ramanathan, James M. Frincke, Elie G. Hanania, Dwight R. Stickney, Mai Ánh Nguyễn, S Buescher, Leon W.M.M. Terstappen, Clarence Ahlem, Yair Gazitt and Sundar Jagannath and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Chris Reading

31 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Reading United States	13	180	173	133	119	98	31	589
Anne-Sophie Govaerts Belgium	17	68 0.4×	172 1.0×	140 1.1×	225 1.9×	120 1.2×	54	708
Antonio Azzarà Italy	13	122 0.7×	110 0.6×	109 0.8×	120 1.0×	84 0.9×	50	495
Richard B. Gayle United States	11	132 0.7×	262 1.5×	195 1.5×	413 3.5×	90 0.9×	16	1.1k
Guy Cornu Belgium	12	133 0.7×	217 1.3×	66 0.5×	55 0.5×	71 0.7×	38	644
Marian Seto United States	10	278 1.5×	290 1.7×	109 0.8×	204 1.7×	91 0.9×	13	829
C. Alexander Valencia United States	15	119 0.7×	368 2.1×	94 0.7×	124 1.0×	64 0.7×	34	725
Fudenberg Hh United States	17	153 0.8×	172 1.0×	66 0.5×	278 2.3×	135 1.4×	58	774
Takafumi Kawanami Japan	17	104 0.6×	228 1.3×	222 1.7×	134 1.1×	58 0.6×	44	849
Naoki Kubota Japan	8	211 1.2×	231 1.3×	233 1.8×	313 2.6×	215 2.2×	14	775

Countries citing papers authored by Chris Reading

Since Specialization

Citations

This map shows the geographic impact of Chris Reading's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Reading with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Reading more than expected).

Fields of papers citing papers by Chris Reading

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Reading. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Reading. The network helps show where Chris Reading may publish in the future.

Co-authorship network of co-authors of Chris Reading

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Reading. A scholar is included among the top collaborators of Chris Reading based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Reading. Chris Reading is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reading, Chris, J R Flores-Riveros, Dwight R. Stickney, & James M. Frincke. (2013). An Anti-Inflammatory Sterol Decreases Obesity-Related Inflammation-Induced Insulin Resistance and Metabolic Dysregulation. Mediators of Inflammation. 2013. 1–16. 6 indexed citations

Aerts‐Kaya, Fatima, Trudi P. Visser, James M. Frincke, et al.. (2012). 5-Androstene-3β,17β-diol Promotes Recovery of Immature Hematopoietic Cells Following Myelosuppressive Radiation and Synergizes With Thrombopoietin. International Journal of Radiation Oncology*Biology*Physics. 84(3). e401–e407. 8 indexed citations

Stickney, Dwight R., Jessie R. Groothuis, Clarence Ahlem, et al.. (2010). Preliminary clinical findings on NEUMUNE as a potential treatment for acute radiation syndrome. Journal of Radiological Protection. 30(4). 687–698. 21 indexed citations

Carrero, Julio César, José Antonio Vargas-Villavicencio, Romel Hernández‐Bello, et al.. (2010). Parasiticidal effect of 16α-bromoepiandrosterone (EpiBr) in amoebiasis and cysticercosis. Microbes and Infection. 12(8-9). 677–682. 4 indexed citations

Villegas, Sonia L., Yujin Huang, Clarence Ahlem, et al.. (2010). Amelioration of Glucose Intolerance by the Synthetic Androstene HE3286: Link to Inflammatory Pathways. Journal of Pharmacology and Experimental Therapeutics. 333(1). 70–80. 25 indexed citations

Ahlem, Clarence, Michael R. Kennedy, Theodore Page, et al.. (2010). 17α-Alkynyl 3α, 17β-androstanediol non-clinical and clinical pharmacology, pharmacokinetics and metabolism. Investigational New Drugs. 30(1). 59–78. 10 indexed citations

Koreckij, Theodore D., Richard Trauger, Bruce Montgomery, et al.. (2009). HE3235 Inhibits Growth of Castration-Resistant Prostate Cancer. Neoplasia. 11(11). 1216–IN23. 15 indexed citations

Montgomery, Bruce, Michael Morris, Charles J. Ryan, et al.. (2009). Abstract A221: Results of preclinical and clinical phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in castrate-resistant prostate cancer. Molecular Cancer Therapeutics. 8(12_Supplement). A221–A221. 1 indexed citations

Trauger, Richard, Eva Corey, Damon A. Bell, et al.. (2009). Inhibition of androstenediol-dependent LNCaP tumour growth by 17α-ethynyl-5α-androstane-3α, 17β-diol (HE3235). British Journal of Cancer. 100(7). 1068–1072. 11 indexed citations

10.

Auci, Dominick L., Laurie J. Kaler, Sandhya Subramanian, et al.. (2007). A New Orally Bioavailable Synthetic Androstene Inhibits Collagen‐Induced Arthritis in the Mouse. Annals of the New York Academy of Sciences. 1110(1). 630–640. 33 indexed citations

11.

Reading, Chris, et al.. (2006). Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16α-bromoepiandrosterone (HE2000). Clinical Microbiology and Infection. 12(11). 1082–1088. 20 indexed citations

12.

Auci, Dominick L., Ferdinando Nicoletti, Katia Mangano, et al.. (2005). Anti-inflammatory and Immune Regulatory Properties of 5-Androsten-3β, 17β-Diol (HE2100), and Synthetic Analogue HE3204: Implications for Treatment of Autoimmune Diseases. Annals of the New York Academy of Sciences. 1051(1). 730–742. 14 indexed citations

13.

Hernández‐Pando, Rogélio, Diana Aguilar‐León, Héctor Orozco, et al.. (2004). 16α‐Bromoepiandrosterone Restores T Helper Cell Type 1 Activity and Accelerates Chemotherapy‐Induced Bacterial Clearance in a Model of Progressive Pulmonary Tuberculosis. The Journal of Infectious Diseases. 191(2). 299–306. 42 indexed citations

14.

Pedersen, Niels C., Thomas W. North, Richard Rigg, et al.. (2003). 16α-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression. Veterinary Immunology and Immunopathology. 94(3-4). 133–148. 18 indexed citations

15.

Zehnder, James L., et al.. (1999). Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD). Leukemia. 13(11). 1833–1842. 45 indexed citations

16.

Tricot, Guido, Yair Gazitt, T Leemhuis, et al.. (1998). Collection, Tumor Contamination, and Engraftment Kinetics of Highly Purified Hematopoietic Progenitor Cells to Support High Dose Therapy in Multiple Myeloma. Blood. 91(12). 4489–4495. 91 indexed citations

17.

Gazitt, Yair & Chris Reading. (1996). Autologous Transplantation with Tumor-Free Graft: A Model for Multiple Myeloma Patients. Leukemia & lymphoma. 23(3-4). 203–212. 7 indexed citations

18.

Przepiorka, Donna, Yang O. Huh, Issa F. Khouri, et al.. (1994). Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.. PubMed. 389. 557–63. 8 indexed citations

19.

Deisseroth, Albert, Hagop M. Kantarjian, Richard Champlin, et al.. (1993). Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients). The University of Texas M.D. Anderson Cancer Center. Human Gene Therapy. 4(6). 821–834. 5 indexed citations

20.

Deisseroth, Albert, Hagop M. Kantarjian, Moshe Talpaz, et al.. (1993). Use of Two Retroviral Markers to Test Relative Contribution of Marrow and Peripheral Blood Autologous Cells to Recovery After Preparative Therapy. The University of Texas M.D. Anderson Cancer Center. Human Gene Therapy. 4(1). 71–85. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact